首页> 外文期刊>Global Journal of Research on Medicinal Plants and Indigenous Medicine >A CLINICAL STUDY ON SHRINGYADI CHURNA WITH AND WITHOUT PRANAYAMA IN THE MANAGEMENT OF TAMAKA SHWASA (BRONCHIAL ASTHMA)
【24h】

A CLINICAL STUDY ON SHRINGYADI CHURNA WITH AND WITHOUT PRANAYAMA IN THE MANAGEMENT OF TAMAKA SHWASA (BRONCHIAL ASTHMA)

机译:支气管哮喘和无支气管哮喘克氏针在治疗TAMAKA SHWASA(支气管哮喘)中的临床研究

获取原文
       

摘要

Tamaka Shwasa is very prevalent medical problem in our country. A better and effective therapy is the need of the hour which may be without many side effects and having quick bronchodilator effects and at the same time within the reach of the masses. The present clinical trial was planned to study the effect of an indigenous compound, “Shringyadi Churna” with and without Pranayama in the management of Tamaka Shwasa. After confirming the diagnosis, patients were randomly distributed in three groups, viz. Group I received Shringyadi Churna with Ushnodaka (Warm Water), Group II received the same with Pranayama, and Group III received Placebo with Pranayama. The duration of trial was 12 weeks and the patients were examined weekly for 6 weeks, there after every three weeks up to 12 weeks. The follow up period was of 2 months. The subjective & objective parameters were measured before & after treatment in each group. The result of ?Shringyadi Churna along with Pranayama? was found to be significant at the level of P<0.001.
机译:Tamaka Shwasa是我国非常普遍的医学问题。更好,更有效的治疗方法是需要数小时的治疗,这可能没有很多副作用,并且具有快速的支气管扩张药作用,同时又在群众的可及范围内。计划进行本临床试验,以研究含或不含Pranayama的本地化合物“ Shringyadi Churna”对Tamaka Shwasa的治疗作用。确认诊断后,将患者随机分为三组。第一组与乌斯诺达卡(暖水)一起接受Shringyadi Churna,第二组与Pranayama一起接受,而第三组与Pranayama一起接受安慰剂。试验时间为12周,每周检查患者6周,之后每3周检查一次,直至12周。随访期为2个月。在各组治疗前后测量主观和客观参数。 Shringyadi Churna和Pranayama的结果?发现在P <0.001的水平上显着。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号